1. Academic Validation
  2. SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia

SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia

  • Sci Adv. 2024 Mar 22;10(12):eadl4018. doi: 10.1126/sciadv.adl4018.
Céline Moison 1 Deanne Gracias 1 Julie Schmitt 1 Simon Girard 1 Jean-François Spinella 1 Simon Fortier 1 Isabel Boivin 1 Rodrigo Mendoza-Sanchez 1 Bounkham Thavonekham 1 Tara MacRae 1 Nadine Mayotte 1 Eric Bonneil 1 Mark Wittman 2 James Carmichael 2 Réjean Ruel 1 Pierre Thibault 1 3 Josée Hébert 1 4 5 Anne Marinier 1 3 Guy Sauvageau 1 4 5
Affiliations

Affiliations

  • 1 Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada.
  • 2 Research and Development, Bristol Myers Squibb Company, Cambridge, MA, USA.
  • 3 Department of Chemistry, Université de Montréal, Montréal, Canada.
  • 4 Division of Hematology-Oncology and Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, Canada.
  • 5 Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, Canada.
Abstract

In a phenotypical screen of 56 acute myeloid leukemia (AML) patient samples and using a library of 10,000 compounds, we identified a hit with increased sensitivity toward SF3B1-mutated and adverse risk AMLs. Through structure-activity relationship studies, this hit was optimized into a potent, specific, and nongenotoxic molecule called UM4118. We demonstrated that UM4118 acts as a copper ionophore that initiates a mitochondrial-based noncanonical form of cell death known as cuproptosis. CRISPR-Cas9 loss-of-function screen further revealed that iron-sulfur cluster (ISC) deficiency enhances copper-mediated cell death. Specifically, we found that loss of the mitochondrial ISC transporter ABCB7 is synthetic lethal to UM4118. ABCB7 is misspliced and down-regulated in SF3B1-mutated leukemia, creating a vulnerability to copper ionophores. Accordingly, ABCB7 overexpression partially rescued SF3B1-mutated cells to copper overload. Together, our work provides mechanistic insights that link ISC deficiency to cuproptosis, as exemplified by the high sensitivity of SF3B1-mutated AMLs. We thus propose SF3B1 mutations as a biomarker for future copper ionophore-based therapies.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-162386
    铜离子载体